HHS OIG General Compliance Program Guidance: An empowered and independent compliance function

Corporate Compliance & Ethics Week 2023 kicked off with a gift for healthcare and life sciences compliance practitioners by way of the U.S. Department of Health and Human Services (HHS) Office of Inspector General’s (OIG) General Compliance Program Guidance, released in November.[1]

Many areas of the guidance covered aspects already familiar to compliance officers from previous guidance; however, one particular area caught my eye: being the first pronouncement of its kind by any compliance regulator, seemingly designed to provide details around OIG’s apparent expectations of what an independent and empowered compliance function would look like.

This document is only available to members. Please log in or become a member.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field